|
|
Novartis is formed from the merger of Sandoz and Ciba Geigy
in 1997. However, we have established our presence in Singapore
since 1971 (Ciba Geigy) and 1986 (Sandoz).
As a leading healthcare company, Novartis is dedicated to improving
health and quality of life through innovative products and services
in the areas of pharmaceuticals, nutrition, eye care and animal
health.
This dedication is reflected in our name - Novartis - which
is derived from the latin word novae artes, signifying
new skills. It reflects our drive to be on the leading
edge of the healthcare industry, a visionary company with
a "product pipeline" filled with remarkable breakthroughs.
Our pharmaceutical products provide treatment for a broad
range of diseases including transplantation and immunology,
oncology, cardiovascular diseases, central nervous system
disorders, endocrine, gastrointestinal, dermatology and ophthalmic
conditions.
Today, Novartis in Singapore is a leading research-based company
with a wide-ranging programme in the development and marketing
of innovative medications in Singapore.
In Singapore and around the world, we are dedicated to the communities
in which we work and to the people we serve. We operate under
this basic tenet, and it is important to us that you are well-informed
about our views and principles. We welcome your interest and
look forward to your input. |
|
|
|